1630 S. Sunkist Street
About ClearFlowClearFlow is a California based medical device company pioneering new technologies to solve the clinical problems associated with obstructed catheters.
ClearFlow was formed from the collaborative efforts of the Cleveland Clinic Foundation and MDI Partners. The company’s product pipeline is based on its proprietary Active Clearance Technology® (ACT) to resolve catheter clogging in multiple medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage.
Founder: Ed Boyle CEO: Paul Molloy
Tweets by ClearFlow
9 articles with ClearFlow
ClearFlow Announces Additional Positive US Clinical Trial Results at the 2018 NTI Critical Care Exposition
ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results were presented at the National Teaching Institute (NTI) & Critical Care Exposition 2018 annual meeting on May 23rd, 2018 in Boston, MA.
ClearFlow Reports: ERAS Cardiac Surgery Recommends Active Tube Clearance Methodology in Consensus Statement Presented at the 98th Annual Meeting of The American Association for Thoracic Surgeons
ClearFlow Inc. has announced that an international society of leading heart surgeons known as ERAS® Cardiac Surgery presented evidenced-based expert consensus statements at the 98th annual meeting of the American Association for Thoracic Surgeons on April 28, 2018.
ClearFlow Release: Studies Recognizing the Importance of Limiting Retained Blood to Prevent Postoperative Atrial Fibrillation Featured on January Cover of Annals of Thoracic Surgery
ClearFlow announced that the cover of the January 2018 issue of The Annals of Thoracic Surgery features a review article that elucidates the biological mechanisms by which retained shed mediastinal blood can trigger postoperative atrial fibrillation (POAF) in susceptible individuals as well as how this could represent a new target for prevention of POAF.
ClearFlow Release: Active Clearance Of Chest Tubes Reduces Bleeding Complications After Left Ventricular Assist Device Implantation For Heart Failure